Simplifying Global Compliance
Articles Tagged with ''Daily International Pharma Alert''
Roche and French drugmaker Transgene announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's line of vaccines against human papillomavirus (HPV)-mediated diseases. Read More
Benda Pharmaceutical announced that, through its Chinese subsidiary Hubei Tongji Benda Ebei Pharmaceutical, it has acquired majority ownership of Shenzhen SiBiono GeneTech for approximately $7.7 million. Read More
Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) has been cracking down on counterfeit drugs in Nigeria, the U.N. Integrated Regional Information Networks (IRIN) reports. Read More
The FDA has ordered companies to stop manufacturing unapproved suppository products containing trimethobenzamide hydrochloride because the drugs lack proof of efficacy. Read More
Lundbeck Pharmaceuticals Italy and MultiCell Technologies have entered into a long-term agreement for the supply of one of the active components of MCT-125, MultiCell's investigational drug for the treatment of chronic fatigue in patients with multiple sclerosis (MS). Read More
The World Health Organization (WHO) and Abbott Laboratories have agreed on an approach to making the HIV drug Kaletra available in the developing world, the company announced. Read More
The U.S. FDA announced it has granted tentative approval to generic abacavir sulfate tablets, 300 mg, manufactured by Matrix Laboratories, under the expedited review provisions developed for the President's Emergency Plan for AIDS Relief (PEPFAR). Read More
VaxGen announced last week it has signed a settlement agreement with the U.S. HHS that releases both parties from all liabilities associated with the company's government contracts to develop and deliver a next-generation anthrax vaccine. Read More
French drugmaker sanofi-aventis has filed suit to prevent Barr Laboratories from launching its own version of the insomnia treatment Ambien. Read More
Schering-Plough announced that PEG-Intron has been approved by the Chinese State Food and Drug Administration (SFDA)for the treatment of chronic hepatitis B, the most prevalent infectious disease in China, according to the company. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing